670 results on '"Onal, Cem"'
Search Results
202. Prostate-specific membrane antigen (PSMA) PET-CT guided radiotherapy in oligometastatic prostate cancer.
203. Determination of Gemifloxacin in Human Serum by Online Heart-Cutting Liquid Chromatography: Application to Pharmacokinetic Study
204. Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy
205. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
206. Review of Current Status of Radiotherapy Facilities and Assessment of Required Time for Radiotherapy Delivery Workflow in Turkey: On Behalf of Turkish Society for Radiation Oncology
207. Daily workflow and workload of radiation oncology specialists in Turkey
208. Review of Current Status of Radiotherapy Facilities and Assessment of Required Time for Radiotherapy Delivery Workflow in Turkey: On Behalf of Turkish Society for Radiation Oncology
209. Prognostic values of ADCmean and SUVmax of the primary tumour in cervical cancer patients treated with definitive chemoradiotherapy.
210. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
211. Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study.
212. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
213. The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients.
214. In regard to Boeri et al. ‘Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience’
215. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images
216. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer
217. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy
218. Dosimetric analysis of testicular doses in prostate intensity-modulated and volumetric-modulated arc radiation therapy at different energy levels
219. Graves’ ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature
220. Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients.
221. Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
222. Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer.
223. Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al.
224. There is no doubt about the winner of the lion–rabbit fight.
225. Longer treatment time and lower radiation doses—an alternative for Graves' ophthalmopathy treatment.
226. CT-Guided Brachytherapy Planning
227. Multifocal soft tissue Langerhans’ cell histiocytosis treated with PET-CT based conformal radiotherapy
228. Isolated jejunal metastasis in a patient with cervical cancer: A case report
229. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy
230. Letter to the editor regarding 'Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis'.
231. Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial.
232. Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
233. Einfluss der Androgendeprivationstherapie auf Konfigurationsfehler bei der externen Strahlentherapie des Prostatakarzinoms.
234. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
235. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
236. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
237. Effects of Setup Errors on Dose Distribution for Tangential Wedge Field and Field-in-Field Techniques During Breast Irradiation
238. Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach
239. Uterine Perforation During 3-Dimensional Image-Guided Brachytherapy in Patients With Cervical Cancer: Baskent University Experience
240. Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer
241. Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
242. The utility of 1.5 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor – Case reports and review of the literature.
243. Prognostic Value of Pretreatment 18F-fluorodeoxyglucose Uptake in Patients With Cervical Cancer Treated With Definitive Chemoradiotherapy
244. Isolated Mediastinal Lymph Node False Positivity of [18F]-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography in Patients With Cervical Cancer
245. Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.
246. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al.
247. Chemotherapy with irradiation in salivary gland carcinomas (SGC): A Rare Cancer Network study (RCN)
248. Evaluation of Field-in-Field Technique for Total Body Irradiation
249. Effect of different prosthetic materials on radiation dose distribution in an orbital defect: A clinical report
250. Correlation of Conventional and Conformal Plan Parameters for Predicting Radiation Pneumonitis in Patients Treated with Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.